BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

895 related articles for article (PubMed ID: 19344979)

  • 1. Autoantibodies against epidermal transglutaminase are a sensitive diagnostic marker in patients with dermatitis herpetiformis on a normal or gluten-free diet.
    Rose C; Armbruster FP; Ruppert J; Igl BW; Zillikens D; Shimanovich I
    J Am Acad Dermatol; 2009 Jul; 61(1):39-43. PubMed ID: 19344979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue transglutaminase and endomysial antibodies-diagnostic markers of gluten-sensitive enteropathy in dermatitis herpetiformis.
    Kumar V; Jarzabek-Chorzelska M; Sulej J; Rajadhyaksha M; Jablonska S
    Clin Immunol; 2001 Mar; 98(3):378-82. PubMed ID: 11237562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgA anti-epidermal transglutaminase autoantibodies: a sensible and sensitive marker for diagnosis of dermatitis herpetiformis in adult patients.
    Borroni G; Biagi F; Ciocca O; Vassallo C; Carugno A; Cananzi R; Campanella J; Bianchi PI; Brazzelli V; Corazza GR
    J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):836-41. PubMed ID: 22672004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermatitis herpetiformis.
    Kárpáti S
    Clin Dermatol; 2012; 30(1):56-9. PubMed ID: 22137227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neo-epitope tissue transglutaminase autoantibodies as a biomarker of the gluten sensitive skin disease--dermatitis herpetiformis.
    Lytton SD; Antiga E; Pfeiffer S; Matthias T; Szaflarska-Poplawska A; Ulaganathan VK; Placek W; Fabbri P; Hall R; Caproni M
    Clin Chim Acta; 2013 Jan; 415():346-9. PubMed ID: 23142793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease.
    Vahedi K; Mascart F; Mary JY; Laberenne JE; Bouhnik Y; Morin MC; Ocmant A; Velly C; Colombel JF; Matuchansky C
    Am J Gastroenterol; 2003 May; 98(5):1079-87. PubMed ID: 12809831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celiac disease serology in dermatitis herpetiformis. Which is the best option for detecting gluten sensitivity?
    Sugai E; Smecuol E; Niveloni S; Vázquez H; Label M; Mazure R; Czech A; Kogan Z; Mauriño E; Bai JC
    Acta Gastroenterol Latinoam; 2006 Dec; 36(4):197-201. PubMed ID: 17225447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel assay for detecting celiac disease-associated autoantibodies in dermatitis herpetiformis using deamidated gliadin-analogous fusion peptides.
    Kasperkiewicz M; Dähnrich C; Probst C; Komorowski L; Stöcker W; Schlumberger W; Zillikens D; Rose C
    J Am Acad Dermatol; 2012 Apr; 66(4):583-8. PubMed ID: 21840083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of a selective epitope loss of anti-transglutaminase immunoreactivity in gluten-free diet celiac sera: a new tool to distinguish disease-specific immunoreactivities.
    Tiberti C; Bonamico M; Dotta F; Verrienti A; Di Tola M; Liu E; Ferri M; Nenna R; Picarelli A; Eisenbarth GS
    Clin Immunol; 2006 Oct; 121(1):40-6. PubMed ID: 16798097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are antiepidermal transglutaminase antibodies titre correlated with dermatitis herpetiformis lesions during the disease follow-up?
    Cozzani E; Pappalardo F; Gasparini G; Gallo F; Drago F; Parodi A
    G Ital Dermatol Venereol; 2018 Oct; 153(5):609-612. PubMed ID: 27845514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/IgG serum antibodies to tissue transglutaminase.
    Dahlbom I; Korponay-Szabó IR; Kovács JB; Szalai Z; Mäki M; Hansson T
    J Pediatr Gastroenterol Nutr; 2010 Feb; 50(2):140-6. PubMed ID: 19841593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transglutaminase autoantibodies in dermatitis herpetiformis and celiac sprue.
    Marietta EV; Camilleri MJ; Castro LA; Krause PK; Pittelkow MR; Murray JA
    J Invest Dermatol; 2008 Feb; 128(2):332-5. PubMed ID: 17762854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevation of IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis.
    Hull CM; Liddle M; Hansen N; Meyer LJ; Schmidt L; Taylor T; Jaskowski TD; Hill HR; Zone JJ
    Br J Dermatol; 2008 Jul; 159(1):120-4. PubMed ID: 18503599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transglutaminases as diagnostically relevant autoantigens in patients with gluten sensitivity.
    Heil PM; Volc-Platzer B; Karlhofer F; Gebhart W; Huber WD; Benesch T; Vogelsang H; Stingl G
    J Dtsch Dermatol Ges; 2005 Dec; 3(12):974-8. PubMed ID: 16405713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenesis of the catalytic triad of tissue transglutaminase abrogates coeliac disease serum IgA autoantibody binding.
    Byrne G; Ryan F; Jackson J; Feighery C; Kelly J
    Gut; 2007 Mar; 56(3):336-41. PubMed ID: 16935926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermatitis herpetiformis: a cutaneous manifestation of coeliac disease.
    Collin P; Salmi TT; Hervonen K; Kaukinen K; Reunala T
    Ann Med; 2017 Feb; 49(1):23-31. PubMed ID: 27499257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermatitis herpetiformis and partial IgA deficiency.
    Samolitis NJ; Hull CM; Leiferman KM; Zone JJ
    J Am Acad Dermatol; 2006 May; 54(5 Suppl):S206-9. PubMed ID: 16631941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatitis Herpetiformis: Novel Perspectives.
    Antiga E; Maglie R; Quintarelli L; Verdelli A; Bonciani D; Bonciolini V; Caproni M
    Front Immunol; 2019; 10():1290. PubMed ID: 31244841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-localization of IgA and TG3 on healthy skin of coeliac patients.
    Cannistraci C; Lesnoni La Parola I; Cardinali G; Bolasco G; Aspite N; Stigliano V; Picardo M
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):509-14. PubMed ID: 17373979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody levels in adult patients with coeliac disease during gluten-free diet: a rapid initial decrease of clinical importance.
    Midhagen G; Aberg AK; Olcén P; Järnerot G; Valdimarsson T; Dahlbom I; Hansson T; Ström M
    J Intern Med; 2004 Dec; 256(6):519-24. PubMed ID: 15554953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.